See clearly
Begin with the biology and follow the evidence.
A health biotechnology company
Janma Bio builds focused ventures around specific, underserved problems in human health — starting with heart health risk in women.
Discover our directionOur direction
We are at the beginning of something important. Janma Bio brings scientific rigor, creative thinking, and a deep respect for biology to problems that existing tools have underserved — one focus area at a time, proven before we add the next.
One focus area active today. More as this one earns it.
Current focus
Diagnostic risk prediction for cardimetabolic disease in [specific indication — e.g. pregnancy-related hypertensive disorders, menopause transition, PCOS], a population existing risk models weren't built to serve well.
This is the only active venture under Janma Bio right now — we're not yet a portfolio.
Begin with the biology and follow the evidence.
Make room for ideas that open new paths forward.
Keep meaningful human impact at the center of the work.
The next chapter